XTL Biopharmaceuticals Ltd. ADR Company Profile
NASDAQ: XTLBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
XTL Biopharmaceuticals at a glance
XTL Biopharmaceuticals Ltd. ADR (NASDAQ: XTLB) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Herzliya, NY, Israel. XTL Biopharmaceuticals is led by Mr. Noam Band and employs about 4 people. At a market capitalization of $3.4 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001023549, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does XTL Biopharmaceuticals do?
XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases in Israel. The company's lead drug candidate is hCDR1, which is a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Herzliya, Israel.
Business description based on the company's public filings.
Company information
- Legal name
- XTL Biopharmaceuticals Ltd. ADR
- Ticker
- NASDAQ: XTLB
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Noam Band
- Employees
- 4
- Headquarters
- 85 Medinat Hayehudim St., Herzliya, NY, Israel
- Phone
- 972 5 4228 8897
- Website
- xtlbio.com
- Market cap
- $3.37M
- SEC CIK
- 0001023549
Companies similar to XTL Biopharmaceuticals
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| XBIOXenetic Biosciences Inc. | 1.40 | -9.09% | $3.28M | vs XTLB |
| IMNNImunon Inc. | 0.5355 | -5.22% | $3.47M | vs XTLB |
| APREAprea Therapeutics Inc. | 0.229 | -53.56% | $3.25M | vs XTLB |
| NRSNNeuroSense Therapeutics Ltd. | 1.28 | +1.59% | $3.19M | vs XTLB |
| KPRXKiora Pharmaceuticals Inc. | 0.7202 | -12.28% | $3.19M | vs XTLB |
| MDCXMedicus Pharma Ltd. | 1.14 | -2.16% | $3.16M | vs XTLB |
| AZTRAzitra Inc | 0.5168 | -2.75% | $3.13M | vs XTLB |
| NCNANuCana plc ADR | 0.7495 | +4.39% | $3.61M | vs XTLB |